Inflixamab (Remicade)

CAS NO: 170277-31-3
Batch Molecular Formula


Batch Molecular Weight

144190.3 g/mol

Physical Appearance


Melting point

61 °C


Store at RT

Batch Molecular Structure


  • Remicade is a treatment used to alleviate the symptoms of pain and inflammation in a range of autoimmune inflammatory diseases especially psoriatic arthritis and various types of Psoriasis,Including chronic plaque psoriasis.


  • Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer’s risk. Most OTC drugs are not reviewed and approved by FDA, however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. This is only for study not for any Human / Veterinary use. (Condition Apply)* Delphis Pharmaceutical India warns the buyers / importers not to use/sell/procure any goods to achieve a product which might be knowingly causing an infringement / controlled / banned drugs. Delphis Pharmaceutical India is not responsible or liable for the same.